Centrica PLC Transaction in Own Shares (5590H)
24 November 2022 - 06:45PM
UK Regulatory (RNS & others)
TIDMCNA
RNS Number : 5590H
Centrica PLC
24 November 2022
Transactions in own shares
Centrica plc
24 November 2022
Centrica plc announces that today it purchased (through UBS AG
London Branch) 2,074,023 Centrica plc ordinary shares of 6 (14)
/(81) pence each at a price of 95.7651 pence per share. The
purchased shares will be held as treasury shares. Such purchase was
effected pursuant to the Company's buyback programme (details of
which were as announced on 15 November 2022) and effected in
accordance with the non-discretionary share repurchase agreement
entered into with UBS AG London Branch, as announced on 15 November
2022.
Since 15 November 2022, Centrica has purchased 8,463,480
ordinary shares at a cost (excluding dealing and associated costs)
of GBP7,790,640.51.
Following the above purchase, Centrica plc holds 8,463,480
ordinary shares in treasury, and has 5,899,382,658 ordinary shares
in issue (excluding treasury shares).
In accordance with Article 5(1)(b) of Regulation (EU) No
596/2014 (the Market Abuse Regulation) (as in force in the UK and
as amended by the Market Abuse (Amendment) (EU Exit) Regulations
2019), detailed information about the individual purchases made by
UBS AG London Branch is set out below.
Transaction details: Centrica plc ordinary shares of 6 (14)
/(81) pence each
Issuer name: Centrica plc
ISIN: GB00B033F229
Intermediary name: UBS AG London Branch
Intermediary Code: UBSWGB2L
Currency: GBP
Aggregated information
Date of purchase: 24 November 2022
Number of ordinary shares purchased: 2,074,023
-----------------
Highest price paid 96.52p
-----------------
Lowest price paid 95.08p
-----------------
Volume weighted average price paid
per share (p): 95.7651p
-----------------
Disaggregated information
The table attached contains detailed information of the
individual trades made by UBS AG London Branch, as part of the
buyback programme.
Click on, or paste the following link into your web browser, to
view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/5590H_1-2022-11-24.pdf
END
Enquiries:
Investors and Analysts
T: 01753 494900
E: ir@centrica.com
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor,
Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
POSZZMZMNDLGZZM
(END) Dow Jones Newswires
November 24, 2022 12:45 ET (17:45 GMT)
Centrica (LSE:CNA)
Historical Stock Chart
Von Nov 2023 bis Dez 2023
Centrica (LSE:CNA)
Historical Stock Chart
Von Dez 2022 bis Dez 2023